Bcl-2 prevents hippocampal cell death induced by the neuroleptic drug haloperidol

Brain Research

Volumn 738, Issue 1, 1996, Pages 176-179

  Lezoualc'h, F ^a   Rupprecht, R ^a   Holsboer, F ^a   Behl, C ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

bcl 2; cell death; haloperidol; HT22 cell; neuroleptic drug; oxidative stress

Indexed keywords

HALOPERIDOL; HYDROGEN PEROXIDE; NEUROLEPTIC AGENT;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HIPPOCAMPUS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0030605108     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00996-1     Document Type: Article

References (24)

1. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
2. Behl C., Rupprecht R., Skutella T., Holsboer F. Haloperidol-induced cell death-mechanism and protection with vitamin E in vitro. NeuroReport. 7:1995;360-364.
3. Behl C., Lezoualc'h F., Widmann M., Rupprecht R., Holsboer F. Oxidative stress-resistant cells are protected against haloperidol toxicity. Brain. Res. 717:1996;193-195.
4. Cadet J.L., Lohr J.B., Jeste D.V. Free radicals and tardive dyskenisia. Trends Neurosci. 9:1989;107-108.
5. Egan M.F., Hyde T.M., Albers G.W., Elkashef A., Alexander R., Reeve A., Blum A., Saenz R.E., Wyatt R.J. Treatment of tardive dyskinesia with vitamin E. Am. J. Psychol. 149:1992;773-777.
6. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/killing. J. Immunol. Methods. 119:1989;203-210.
7. Hockenbery D.M., Nunez G., Milliman C.L., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348:1990;334-336.
8. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
9. Jacobson M.D., Burne J.F., King M.P., Miyashita T., Reed J.C., Raff M.C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature. 361:1993;365-369.
10. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neuronal death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
11. Kane D.J., Ord T., Anton R., Bredesen D.E. Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40:1995;269-275.
12. Korsmeyer S.J. Bcl-2: An antidote to programmed cell death. Cancer Surveys. 15:1992;105-118.
13. Lohr J.B., Caligiuri M.P. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J. Clin. Psychiatry. 57:1996;167-173.
14. Monaghan P., Robertson T., Amos T.A.S., Dyer M.J., Mason M.Y., Greaves M.F. Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem. 40:1992;1819-1825.
15. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
16. Oltvai Z., Milliman C., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
17. Sagara Y., Dargusch R., Klier F.G., Schubert D., Behl C. Increased antioxidant enzyme activity in amyloid β protein-resistant cells. J. Neurosci. 16:1996;497-505.
18. Satou T., Cummings B.J., Cotman C.W. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain. Res. 697:1995;35-43.
19. Shearman M.S., Ragan C.I., Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
20. Su H.J., Satou T., Anderson A.J., Cotman C.W. Up-regulation of bcl-2 is associated with neuronal DNA damage in Alzheimer's disease. NeuroReport. 7:1996;437-440.
21. Vilner B.J., Bowen W.D. Sigma receptor-active neurleptics are cytotoxic to C6 glioma cells in culture. Eur. J. Pharmacol. 244:1993;199-201.
22. Vilner B.J., deCosta B.R., Bowen W.D. Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability. J. Neurosci. 15:1995;117-134.
23. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
24. Zhong L.T., Sarafian T., Kane D.J., Charles A.C., Mah S., Edwards R.H., Bredesen D.E. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA. 90:1993;4533-4537.